Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
TL;DR Retatrutide (development code LY3437943 ) is the first and, as of 2026, only known synthetic peptide to simultaneously activate all three incretin/glucagon-family receptors: GLP-1, GIP, and glucagon
However, further studies are needed to unfold effect of GSNO in high altitude hypoxic condition
Applicable Procedure Codes: 0094U, 0212U, 0213U, 0214U, 0215U, 0260U, 0264U, 0265U, 0266U, 0267U, 0318U, 0336U, 0425U, 0426U, 0454U, 0469U, 0532U, 0567U, 0582U, 0583U, 0657U, 0658U, 0659U, 81354, 81415, 81416, 81417, 81427
Klow peptide is a branded term commonly used to describe multi-peptide formulations rather than a single isolated compound
US$ 22.22
US$ 27.67
US$ 25.11
US$ 29.56
US$ 21.70
US$ 23.22
US$ 25.12
US$ 24.46
US$ 21.73
